Myriad Genetics Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

7.20

-0.30 (-4.00%)

At close: Apr 29, 2025, 3:59 PM

7.20

0.00%

After-hours: Apr 29, 2025, 04:11 PM EDT

Myriad Genetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Cash & Equivalents	132.1M	56.9M	258.4M	117M	93.2M	93.2M	110.9M	102.4M
Short-Term Investments	8.8M	58M	81.4M	33.7M	43.7M	43.7M	69.7M	48.3M
Long-Term Investments	n/a	54.8M	59M	21M	54.9M	54.9M	30.7M	48.5M
Other Long-Term Assets	15.4M	15.5M	8.3M	-1.03B	n/a	-1.21B	n/a	n/a
Receivables	114.3M	101.6M	91.3M	89.5M	138.6M	138.6M	102.1M	111.3M
Inventory	22M	20.1M	15.3M	27.1M	31.4M	31.4M	34.3M	42.2M
Other Current Assets	19.4M	20.4M	38.4M	122.1M	41.7M	46.4M	9.4M	12.9M
Total Current Assets	313.6M	274.6M	484.8M	389.4M	348.6M	348.6M	326.4M	317.1M
Property-Plant & Equipment	180.6M	187.3M	125.3M	100.4M	57.3M	57.3M	43.2M	51.1M
Goodwill & Intangibles	636.9M	666.5M	643.3M	908M	1.1B	1.1B	773.8M	807.7M
Total Long-Term Assets	832.9M	924.1M	835.9M	1.03B	1.21B	1.21B	847.7M	907.3M
Total Assets	1.15B	1.2B	1.32B	1.42B	1.56B	1.56B	1.17B	1.22B
Account Payables	25.8M	28.8M	29.6M	20.5M	33.3M	33.3M	26M	22M
Deferred Revenue	n/a	600K	5.2M	n/a	2.2M	2.2M	2.6M	2.6M
Short-Term Debt	n/a	14.1M	13M	n/a	78.9M	78.9M	68.3M	65.6M
Other Current Liabilities	38.2M	93.7M	156.5M	125.4M	3.4M	82.3M	5.3M	127.3M
Total Current Liabilities	155.9M	137.2M	204.3M	145.9M	117.8M	117.8M	102.2M	217.5M
Long-Term Debt	38.5M	130.9M	79.3M	224.8M	233.5M	233.5M	9.3M	99.1M
Other Long-Term Liabilities	71.5M	41.3M	33.5M	-224.8M	39.9M	39.9M	40.4M	45.6M
Total Long-Term Liabilities	207.4M	175.7M	148.6M	224.8M	356M	356M	107M	229.1M
Total Liabilities	363.3M	312.9M	352.9M	537.8M	473.8M	473.8M	209.2M	446.6M
Total Debt	152.1M	145M	92.3M	n/a	233.5M	233.5M	9.3M	99.1M
Common Stock	900K	800K	800K	800K	700K	700K	700K	700K
Retained Earnings	-629.5M	-366.2M	-254.2M	-227M	25.6M	25.6M	52.8M	-68.4M
Comprehensive Income	-3.7M	-8.9M	-5.1M	n/a	-5.4M	-5.4M	-4M	-5.5M
Shareholders Equity	783.2M	885.8M	967.8M	881M	1.09B	1.09B	964.9M	778.2M
Total Investments	8.8M	112.8M	140.4M	54.7M	98.6M	98.6M	100.4M	96.8M